[Non-Small Cell Lung Cancer - Development of Parallel Mechanisms of Resistance].
This report is describing the case of a patient who developed parallel two different mechanisms of resistance: A T790 M resistance mutation and a transformation into a small cell neuroendocrine cancer. Under therapy with Osimertinib and chemotherapy with carboplatin and etoposide the tumor responsed partially.
PMID: 29466812 [PubMed - as supplied by publisher]
Source: Pneumologie - Category: Respiratory Medicine Tags: Pneumologie Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Respiratory Medicine